J Korean Diabetes.  2022 Mar;23(1):43-49. 10.4093/jkd.2022.23.1.43.

The Occurrence and Management of Adverse Skin Events due to Continuous Glucose Monitoring

• Lee JH

• KMID: 2528410
• DOI: http://doi.org/10.4093/jkd.2022.23.1.43

Abstract

The use of continuous glucose monitoring (CGM) for blood glucose control is increasing and is effective in changing treatment methods and improving lifestyle by identifying problems in blood sugar patterns. However, adverse skin events are increasing due to the insertion of invasive tools or attachment of sensors to the skin for 14 days for intermittent CGM. These adverse events can be the reason for the discontinuation of CGM. Therefore, this paper aims to determine methods to identify and manage skin irritation and side effects caused by CGM accessories.

Keyword

Adverse events; Continuous glucose monitoring; Diabetes mellitus; Skin

Reference

1.Kim JH. Recent opinion of glucose monitoring in patients of diabetes. Available from: https://www.kaim.or.kr/schedule/abstract_view.php?sid=177980.

2.Kroeger J., Fasching P., Hanaire H. Meta-analysis of three real-world, chart review studies to determine the effective-ness of FreeStyle Libre flash glucose monitoring system on HbA1c in adults with type 2 diabetes. Diabetes. 2019. 68(Suppl 1):99–LB.

3.Jin SM. The present and future of continuous glucose monitoring. J Korean Diabetes. 2020. 21:179–83.

4.Bolinder J., Antuna R., Geelhoed-Duijvestijn P., Kröger J., Weitgasser R. Cutaneous adverse events related to FreeStyle Libre device- authors' reply. Lancet. 2017. 389:1396–7.

5.Gatica-Ortega ME., Pastor-Nieto MA., Torres-Aranda R., Luna-Bastante L., Pérez-Hortet C. Contact dermatitis from MiaoMiao (an add-on transmitter to FreeStyle Libre flash glucose monitoring system). Contact Dermatitis. 2021. 85:92–4.

6.Kamann S., Oppel E. Hydrocolloid blister plaster decreases allergic contact dermatitis caused by Freestyle Libre and isobornyl acrylate. Contact Dermatitis. 2019. 81:380–1.

7.Aerts O., Herman A., Bruze M., Goossens A., Mowitz M. FreeStyle Libre: contact irritation versus contact allergy. Lancet. 2017. 390:1644.

8.Herman A., Aerts O., Baeck M., Bruze M., De Block C., Goossens A, et al. Allergic contact dermatitis caused by isobornyl acrylate in Freestyle^® Libre, a newly introduced glucose sensor. Contact Dermatitis. 2017. 77:367–73.

9.Herman A., de Montjoye L., Marot L., Baeck M. Induction of leukoderma following allergic contact dermatitis to FreeStyle Libre. Contact Dermatitis. 2019. 81:456–8.

10.Mine Y., Urakami T., Matsuura D. Allergic contact dermatitis caused by isobornyl acrylate when using the FreeStyle^® Libre. J Diabetes Investig. 2019. 10:1382–4.

11.Shinkawa E., Washio K., Tatsuoka S., Fukunaga A., Sakagu-chi K., Nishigori C. A case of contact dermatitis caused by isobornyl acrylate in FreeStyle Libre: the usefulness of film-forming agents. Contact Dermatitis. 2019. 81:56–7.

12.Ogawa W., Hirota Y., Osonoi T., Tosaki T., Kato Y., Utsu-nomiya K, et al. Effect of the FreeStyle Libre^TM flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal-bolus insulin ther-apy: an open label, prospective, multicenter trial in Japan. J Diabetes Investig. 2021. 12:82–90.

13.Englert K., Ruedy K., Coffey J., Caswell K., Steffen A., Le-vandoski L. Skin and adhesive issues with continuous glucose monitors: a sticky situation. J Diabetes Sci Technol. 2014. 8:745–51.

14.Feig DS., Donovan LE., Corcoy R., Murphy KE., Amiel SA., Hunt KF, et al. Continuous glucose monitoring in preg-nant women with type 1 diabetes (CONCEPTT): a mul-ticentre international randomised controlled trial. Lancet. 2017. 390:2347–59. Erratum in: Lancet 2017;390:2346.

15.Berg AK., Olsen BS., Thyssen JP., Zachariae C., Simonsen AB., Pilgaard K, et al. High frequencies of dermatological complications in children using insulin pumps or sensors.

16.Messer LH., Berget C., Beatson C., Polsky S., Forlenza GP. Preserving skin integrity with chronic device use in diabetes. Diabetes Technol Ther. 2018. 20(S2):S254–64.

17.McNichol L., Lund C., Rosen T., Gray M. Medical adhesives and patient safety: state of the science: consensus statements for the assessment, prevention, and treatment of adhesive-related skin injuries. J Wound Ostomy Conti-nence Nurs. 2013. 40:365–80. quiz E1-2.

18.Bryant RA. Saving the skin from tape injuries. Am J Nurs. 1988. 88:189–91.

19.Medtronic Diabetes. Tape tips and site management. Available from: https://www.medtronicdiabetes.com/sites/default/files/library/download-library/workbooks/Tape%20Tips%20and%20Site%20Management.pdf.

20.Eichenfield LF., Tom WL., Berger TG., Krol A., Paller AS., Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014. 71:116–32.

21.Dexcom, Inc. 2020. Available from: https://s3-us-west-2.amazonaws.com/dexcompdf/LBL019184_irritated_or_sensitive_skin_OUS.pdf (updated 2020).

22.Chase HP., Messer L. Understanding insulin pumps, continuous glucose monitors, and the artificial pancreas. 3rd ed.Denver: Children's Diabetes Foundation;2016.

23.Ives B., Sikes K., Urban A., Stephenson K., Tamborlane WV. Practical aspects of real-time continuous glucose monitors: the experience of the Yale Children's Diabetes Pro-gram. Diabetes Educ. 2010. 36:53–62.

24.Karlin AW., Ly TT., Pyle L., Forlenza GP., Messer L., Wadwa RP, et al. Duration of infusion set survival in lipohypertro-phy versus nonlipohypertrophied tissue in patients with type 1 diabetes. Diabetes Technol Ther. 2016. 18:429–35.